Association of Single-Nucleotide Variants in the Human Leukocyte Antigen and Other Loci With Childhood Hodgkin Lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.25647
Abstract: Key Points Question What genetic variants or genes are associated with the risk of childhood Hodgkin lymphoma? Findings In this genetic association study nested within 3 childhood cancer survivor cohorts, 3 independent single-nucleotide variants (SNVs,… read more here.
Keywords: nucleotide variants; hodgkin lymphoma; childhood; single nucleotide ... See more keywords
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.7975
Abstract: Importance To our knowledge, this is the first clinical trial designed to investigate concurrent treatment with a checkpoint inhibitor and conventional chemotherapy in relapsed or refractory classic Hodgkin lymphoma in patients destined for an autologous… read more here.
Keywords: hodgkin lymphoma; relapsed refractory; refractory classic; chemotherapy ... See more keywords
Hodgkin lymphoma: A 2020 update on diagnosis, risk‐stratification, and management
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Hematology"
DOI: 10.1002/ajh.25856
Abstract: Hodgkin lymphoma (HL) is an uncommon B‐cell lymphoid malignancy affecting 8480 new patients annually and representing approximately 10% of all lymphomas in the United States. read more here.
Keywords: lymphoma; diagnosis risk; 2020 update; hodgkin lymphoma ... See more keywords
Eosinophil morphology in the reactive eosinophilia of Hodgkin lymphoma
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Hematology"
DOI: 10.1002/ajh.26337
Abstract: A 35-year-old woman with stage IVB refractory Hodgkin lymphoma, mixed cell type, who had initially presented 18 months earlier, developed marked leukocytosis with striking eosinophilia with disease progression. The eosinophils showed notable morphological abnormalities (all… read more here.
Keywords: reactive eosinophilia; eosinophil morphology; morphology reactive; hodgkin lymphoma ... See more keywords
Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2981
Abstract: Cancer‐related psychological distress may lead to depression and anxiety among survivors. The vast majority of patients with Hodgkin lymphoma (HL) become long‐term survivors, but the risk of mental health problems after HL is not well‐characterized.… read more here.
Keywords: risk; hodgkin lymphoma; anxiety; psychotropic drug ... See more keywords
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5631
Abstract: Relapsed or refractory Hodgkin lymphoma (R/R HL) is a challenging disease with limited treatment options beyond brentuximab vedotin and checkpoint inhibitors. Herein we present the time‐trend analysis of R/R HL patients who received allogeneic hematopoietic… read more here.
Keywords: hodgkin lymphoma; allogeneic hematopoietic; refractory hodgkin; relapsed refractory ... See more keywords
Hodgkin lymphoma classification: Are we at a crossroads?
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30824
Abstract: Hodgkin lymphoma (HL) has been classified into 2 categories: classic Hodgkin lymphoma (CHL), which accounts for 95% of all HL cases, and the less common nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). CHL is a distinct neoplastic… read more here.
Keywords: lymphoma; classification; hodgkin lymphoma; chl ... See more keywords
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis
Sign Up to like & getrecommendations! Published in 2018 at "Cancer"
DOI: 10.1002/cncr.30979
Abstract: There is no clear consensus between pediatric and adult providers about the treatment of adolescents and young adults (AYAs) with Hodgkin lymphoma (HL). read more here.
Keywords: adult; hodgkin lymphoma; adolescents young; group ... See more keywords
Risk of venous thromboembolism in patients with non‐Hodgkin lymphoma surviving blood or marrow transplantation
Sign Up to like & getrecommendations! Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32488
Abstract: Patients with non‐Hodgkin lymphoma (NHL) have an increased risk of venous thromboembolism (VTE), particularly when they are receiving treatment. Blood or marrow transplantation (BMT) is recommended for relapsed/refractory NHL, and the risk of VTE after… read more here.
Keywords: risk venous; risk; hodgkin lymphoma; patients non ... See more keywords
Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34359
Abstract: Long‐term mental health outcomes were characterized in patients who were diagnosed with Hodgkin lymphoma (HL), and risk factors for the development of mental health disorders were identified. read more here.
Keywords: health; hodgkin lymphoma; disorders common; health disorders ... See more keywords
Long‐term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34375
Abstract: The temporal trend of cardiovascular disease (CVD) mortality in patients with classic Hodgkin lymphoma (cHL) throughout follow‐up remains unclear. This study aimed to assess this temporal trend in patients with cHL. read more here.
Keywords: cardiovascular disease; mortality; hodgkin lymphoma; classic hodgkin ... See more keywords